SCHEMBL4444286

SCHEMBL4444286

O=C(O)N1CCN(c2cc(-c3ccc(Br)cc3)c(C(F)(F)F)nn2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 1/20 0.38
▸ MET P08581 1/20 0.37
▸ IDO1 P14902 1/20 0.36
▸ TDO2 P48775 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ HPGD P15428 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ TRPV1 Q8NER1 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ SLC6A7 Q99884 1/20 0.34
▸ AKR1C3 P42330 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ SCD O00767 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4443140 0.89 KDM4E (0.41) CCR1METIDO1TDO2HPGD
SCHEMBL4443105 0.88 KDM4E (0.40) CCR1METIDO1TDO2HPGD
SCHEMBL2966669 0.85 RET (0.44) ALDH1A1LMNAMAPT
SCHEMBL27764701 0.81 ADRA2B (0.37) CCR1METADRA2BALDH1A1SMN1; SMN2
SCHEMBL4435035 0.76 IDO1 (0.41) IDO1TDO2HPGDALDH1A1LMNA
SCHEMBL2958371 0.76 CKS1B (0.55) METALDH1A1MAPT
Tert-Butyl Formate SCHEMBL27764702 0.73 ADRA2B (0.38) ADRA2B
SCHEMBL27786505 0.72 CSNK1D (0.40) METHPGDALDH1A1LMNATP53
SCHEMBL4438731 0.70 ALDH1A1 (0.44) HPGDALDH1A1LMNATP53KDM4E
SCHEMBL2954143 0.70 MAPK14 (0.60) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121630-A1 FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS Janssen Pharmaceutica, N.V. (BE) 2009-11-25 — — EP disclosed
WO-2008098892-A1 FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-21 — — WO disclosed
Send feedback